Dendritic cell maturation in active immunotherapy strategies

Author： Morse Michael A   Mosca Paul J   Clay Timothy M   Lyerly H Kim  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.2, Iss.1, 2002-01, pp. : 35-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dendritic cell-based active specific immunotherapy for malignant glioma

By Parajuli Prahlad   Mathupala Saroj   Mittal Sandeep   Sloan Andrew E  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 4, 2007-04 ,pp. : 439-448

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cell immunotherapy for breast cancer

By Pinzon-Charry Alberto   Schmidt Chris   López José Alejandro  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 6, 2006-06 ,pp. : 591-604

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cell fusion vaccines for cancer immunotherapy

By Rosenblatt Jacalyn   Kufe Donald   Avigan David  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 5, 2005-05 ,pp. : 703-715

Informa Healthcare

Access to resources Recommend Favorite

RNA transfer and its use in dendritic cell-based immunotherapy

By Gust Tatjana C   Zenke Martin  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 2, 2005-02 ,pp. : 173-181

Informa Healthcare

Access to resources Recommend Favorite

Natural killer–dendritic cell cross-talk in cancer immunotherapy

By Kalinski Pawel   Mailliard Robbie B   Giermasz Adam   Zeh Herbert J   Basse Per   Bartlett David L   Kirkwood John M   Lotze Michael T   Herberman Ronald B  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 10, 2005-10 ,pp. : 1303-1315

Informa Healthcare

Access to resources Recommend Favorite